IBEC researchers appear in different media for the recent study senior-authored by Joan Montero and first-authored by Albert Manzano, Senior Researcher and PhD student in IBEC’s Nanobioengineering group in which they have used a state-of-the-art analysis technique to evaluate new drug combinations to successfully treat acute lymphoblastic leukemia.
IBEC researchers have used a state-of-the-art analysis technique to evaluate new drug combinations to successfully treat acute lymphoblastic leukemia. This study brings personalised medicine closer to the clinic for this cancer type.
Researchers led by Pere Roca-Cusachs appear in different media for their study published in the prestigious journal “Nature Communications” that discovers how force dynamics affect cells, and living tissues.
Researchers, led by Pere Roca-Cusachs at the Institute for Bioengineering of Catalonia (IBEC) discover how force dynamics affect cells, and living tissues. The results give an insight into the critical mechanical processes that occur in different diseases such as cancer.
A 3-years research project led by the ICREA Research Professor at IBEC, Núria Montserrat, has been dedicated to study kidney cancer by using laboratory organoids, thanks to the “LAB 2017” grants from the Spanish Association Against Cancer (AECC). Researchers have managed to create the first renal organoid-based animal model for this type of cancer, and to identify early signs of the development of the disease.
The Vall d’Hebron Research Institute (VHIR) and the Institute for Bioengineering of Catalonia (IBEC) intensify their collaboration to face health challenges. With the last translational conferences, both institutions reinforce the alliance signed in 2012 to address, among others, infectious, neurodegenerative diseases, rare diseases, tissue regeneration, pediatric cancer or Parkinson’s.
The association of “Families and Friends of Children with Neuroblastoma” (NEN) and IBEC sign a collaboration agreement to search for new therapeutic markers for this type of cancer, through the generation of models based on engineering techniques. The project will be led by Dr. Áranzazu Vilasante, IBEC researcher.
Roger Oria appears in “la Vanguardia” after receiving the 24th Doctors’ Senate Award of the University of Barcelona (UB) for his thesis on mechanobiology, directed by Pere Roca-Cusachs, principal investigator at IBEC and Associate Professor at the UB’s Faculty of Medicine and Health Sciences.
Roger Oria wins the XXIV Doctors’ Senate Award of the University of Barcelona (UB) for his thesis on mechanobiology, an emerging discipline that can help identify new tools to stop pathologies associated with tissue stiffness, such as cancer.
Nanomed, the Spanish nanomedicine platform coordinated by the Institute for Bioengineering of Catalonia (IBEC), organized with the Germans Trias i Pujol Institute (IGTP), the sixth edition of a conference designed to present the advances against cancer, from early diagnosis and controlled drug release, up to nanoparticle radiation therapy.